Bristol Myers Squib & Celgene–Starboard Objections Addressed Today- Successful Deal Closure Probable
Follow Antya Investments The proposed Bristol Myers Squibb Co (BMY US) & Celgene Corp (CELG US) transaction announced in the first week of 2019, garnered many sceptical comments. Starboard Value jumped in the fray by writing a letter denouncing the transaction while one of the largest holders of BMY, Wellington Management Group, holding about 7.7% […]